QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 27.35

-0.5%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: steve dietrich who wrote (295)	1/3/1997 5:49:00 AM
From: Mike Relyea	of 1693

Happy New Year to everyone! It'll be a good one for Quidel and Quidel's investors. Here's something to keep the interest alive: The 13 January 1997 Business Week cover story features the top 25 managers of the year. One is Sir Richard Sykes, Glaxo's CEO. A short article mentions that even as Zantac sales slid, Glaxo's 1997 could be rough, but upcoming AIDS and flu treatments should be big hits down the road. Sounds like the author thinks Glaxo's flu treatment will be successful. Let's hope so. If it is, and Quidel successfully develops a companion flu test, BOTH the treatment and test will be big hits down the road. Just remember, Principal's 7 October 1996 investment research report didn't even consider Quidel's pipeline products. It said, "At its current price, we believe Quidel's stock does not fully reflect the value of the company's existing business and includes little, if any, value for the potential from new products under development." Basically, were getting the speculation for free. I hope we hear an announcement soon that Glaxo is proceeding with Phase III for GG167. It could be enough to give Quidel a bump on the developing speculation. businessweek.com Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next